Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study

Rezultati

Naziv:	Pomalidomide and Dexamethasone with or without Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Updated Analysis of the Phase 3 Apollo Study
Autori :	Sonneveld, Pieter; ...; Bila, Jelena S. ; ...; (broj koautora 21)
Godina:	2021
Publikacija:	Blood (63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, Dec 11-14, 2021)
ISSN:	0006-4971 Blood Pretraži identifikator
Izdavač:	[New York] : Elsevier
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 138 br. Suppl 1 str. 2747
DOI:	10.1182/blood-2021-146907
WoS-ID:	000736413903045
URI:	https://enauka.gov.rs/handle/123456789/806576
URL:	https://ashpublications.org/blood/article/138/Supplement%201/2747/481396/Pomalidomide-and-Dexamethasone-with-or-without
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

1
OpenCitations

2
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.